Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AXSM stock hub

Axsome Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AXSMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

AXSM

In the news

Latest news · AXSM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-349.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-40.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AXSM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

USD

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001579428
Company name	Axsome Therapeutics, Inc.
Country	United States
Country code	US
Cusip	05464T104
Employees	1,220
Employees Change	508%
Employees Change Percent	71.35
Enterprise value	$11.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-11-19
Isin	US05464T1043
Last refreshed	2026-05-10
Market cap	$11.2B
Market cap category	Large-Cap
Price	$217
Price currency	USD
Rev Per Employee	580,521.31x
Sector	Healthcare
Sic	2834
Symbol	AXSM
Website	https://www.axsome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.68%
EV Sales Forward	9.86x
EV/Sales	15.67x
FCF yield	-0.63%
P/B ratio	204.77x
P/S ratio	15.79x
PS Forward	9.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.93%
EBITDA Margin	-23.61%
Gross margin	92.6%
Gross Profit	$655.8M
Gross Profit Growth	65.88%
Gross Profit Growth Q	58.03%
Gross Profit Growth3 Y	70.22%
Net Income	$-188.3M
Net Income Growth Years	1%
Pretax Margin	-26.66%
Profit Margin	-26.59%
Profit Per Employee	$-154,347
ROA	-16.84
Roa5y	-35.63
ROCE	-64.33
ROE	-349.4
Roe5y	-228.7
ROIC	-40.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	34.33%
Cagr1y	96.18%
Cagr3y	43.37%
Cagr5y	30.72%
EPS Growth Years	1
Revenue Growth	63.88x
Revenue Growth Q	57.42x
Revenue Growth Quarters	8x
Revenue Growth Years	3x
Revenue Growth3 Y	69.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.08
Assets	$713.6M
Cash	$305.1M
Current Assets	$611.2M
Current Liabilities	$439.2M
Debt	$219.9M
Debt Equity	$4.03
Equity	$54.6M
Interest Coverage	-12.83
Liabilities	$659M
Long Term Assets	$102.4M
Long Term Liabilities	$219.8M
Net Cash	$85.2M
Net Cash By Market Cap	$0.76
Net Cash Growth	-4.99%
Net Debt Equity	$-1.56
Tangible Book Value	$3.6M
Tangible Book Value Per Share	$0.07
WACC	7.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.39
Inventory Turnover	2.19
Net Working Capital	$-59.3M
Quick ratio	1.27
Working Capital	$172M
Working Capital Turnover	$3.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.24%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,811.87%
1Y total return	96.09%
200-day SMA	150.4
3Y total return	194.79%
50-day SMA	176.7
50-day SMA vs 200-day SMA	50over200
5Y total return	281.64%
All Time High	234.3
All Time High Change	-7.22%
All Time High Date	2026-05-04
All Time Low	1.94
All Time Low Change	11,105.15%
All Time Low Date	2018-12-27
ATR	9.08
Beta	0.58
Beta1y	0.32
Beta2y	0.81
Ch YTD	19.02
High	223.4
High52	234.3
High52 Date	2026-05-04
High52ch	-7.22%
Low	216.8
Low52	96.09
Low52 Date	2025-08-04
Low52ch	126.23%
Ma50ch	23%
Premarket Change Percent	0
Premarket Price	$220
Price vs 200-day SMA	44.55%
RSI	71.57
RSI Monthly	77.13
RSI Weekly	75.18
Sharpe ratio	1.73x
Sortino ratio	3.61
Total Return	-4.24%
Tr YTD	19.02
Tr1m	28.83%
Tr1w	5.25%
Tr3m	19.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	12
Analyst Price Target Top	$242
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.83
Earnings Revenue Estimate	190,282,944x
Earnings Revenue Estimate Growth	56.66x
Operating Income	$-176.5M
Operating margin	-24.93
Price target	$244
Price Target Change	$12.25
Price Target Change Top	$11.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,546,153%
Float Percent	84.62%
Net Borrowing	-4,383,000
Shares Insiders	1.11%
Shares Institutions	76.1%
Shares Out	51,459,766
Shares Qo Q	1.12%
Shares Yo Y	4.24%
Short Float	6.15%
Short Ratio	4.54
Short Shares	5.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-164.9M
Average Volume	912,626.3x
Bv Per Share	1.06
CAPEX	$-263,000
Ch10y	1,811.9
Ch1m	28.83
Ch1w	5.25
Ch1y	96.09
Ch3m	19.08
Ch3y	194.8
Ch5y	281.6
Ch6m	57.35
Change	-1.29%
Change From Open	-1.44
Close	220.2
Days Gap	0.15
Depreciation Amortization	9,298,000
Dollar Volume	124,823,726.2
Earnings Date	2026-05-04
Earnings Time	bmo
EBIT	$-176.5M
EBITDA	$-167.2M
EPS	$-3.74
F Score	4
FCF	$-71M
FCF EV Yield	-0.64x
FCF Per Share	$-1.38
Financing CF	75,189,000
Fiscal Year End	December
Founded	2,012
Goodwill	12,042,000
Income Tax	$-530,000
Investing CF	-263,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-23
Ma150	162.4
Ma150ch	33.82%
Ma20	196.2
Ma20ch	10.79%
Net CF	4,196,000
Next Earnings Date	2026-08-03
Open	220.6
Optionable	Yes
Position In Range	9.16
Post Close	217.4
Postmarket Change Percent	-0.86
Postmarket Price	$216
Ppne	20,581,000
Pre Close	220.2
Price Date	2026-05-08
Ptbv Ratio	3,109
Relative Volume	0.63x
Revenue	708,236,000x
SBC By Revenue	13.26x
Share Based Comp	93,882,000
Tax By Revenue	-0.07x
Tr6m	57.35%
Us State	New York
Volume	574,219
Z Score	3.81

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AXSM pay a dividend?

Capital-return profile for this ticker.

Performance

AXSM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AXSM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.1%

Float: +84.6% of shares outstanding

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

AXSM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.6

Above 70: short-term overbought

Price vs 200-day MA

+44.5%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AXSM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current AXSM stock rating?

Axsome Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full AXSM analysis?

The full report lives at /stocks/AXSM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for AXSM?

The latest report frames AXSM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the AXSM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.